Bound Therapeutics logo — Safe and effective next generation RNA therapeutics

Bound Therapeutics

Safe and effective next generation RNA therapeutics

Founded 2015 United States Cherry Hill, United States 3 employees Biopharma, Biotechnology +2

General Information

Company Name Bound Therapeutics
Founded Year 2015
Location United States Cherry Hill, United States
Employees 3
Industries Biopharma, Biotechnology, Health Care +1
Social

BounceWatch is an independent company data service, not affiliated with Bound Therapeutics. To contact Bound Therapeutics, visit boundtherapeutics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Bound Therapeutics

Bound Therapeutics is a biotech company founded in 2015, dedicated to the development of safe and effective next generation RNA therapeutics. The company specializes in a cancer cell-specific drug delivery system based on antisense oligonucleotides and targeting ligands, with a lead molecule in development for the treatment of triple negative breast cancer. It operates in the Biopharma, Biotechnology, Health Care, and Pharmaceutical industries, with its headquarters based in the United States. The company's innovative approach to drug delivery and focus on addressing unmet medical needs positions it as a promising player in the biotech industry. Although specific details about its latest investment are not available, Bound Therapeutics' pioneering technology and potential to impact the treatment of cancer could attract significant interest from venture capital firms looking to invest in breakthrough healthcare solutions.

Taxonomy: Biotech, Cancer Treatment, RNA Therapeutics, Antisense Oligonucleotides, Drug Delivery, MicroRNA Therapeutics, Drug Discovery, Oncology, Targeted Therapy, Triple Negative Breast Cancer, Precision Medicine

No funding data available for Bound Therapeutics yet.

Bound Therapeutics Alternatives & Competitors

Bound Therapeutics vs

Delivering a cancer-free future

Post-IPO Equity
11 employees
Biotechnology, Health Care
Bound Therapeutics vs

A clinical stage biopharmaceutical company designing precise cancer therapeutics to address unmet me...

Series A
22 employees
Biotechnology, Health Care
Bound Therapeutics vs

Advancing a new paradigm of precision oncology with a RNA-based approach to match patients to novel,...

Venture round
8 employees
Biopharma, Biotechnology

FAQ About Bound Therapeutics

Safe and effective next generation RNA therapeutics
Bound Therapeutics was founded in 2015.
Bound Therapeutics is headquartered in Cherry Hill, United States.
Bound Therapeutics operates in Biopharma, Biotechnology, Health Care and Pharmaceutical. Its work centres on Biotech, Cancer Treatment, RNA Therapeutics and Antisense Oligonucleotides.
Bound Therapeutics has approximately 3 employees.
Top alternatives and competitors to Bound Therapeutics include TransCode Therapeutics, Inc., Phoenix Molecular Designs, OncXerna Therapeutics , Theramir Ltd, Pannex Therapeutics Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Bound Therapeutics and TransCode Therapeutics, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Bound Therapeutics, https://bouncewatch.com/company/bound-therapeutics, updated 29 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes